Gland Pharma, NCC, Vi, Amber Enterprises among buzzing stocks as SENSEX, NIFTY50 trade flat

The Indian benchmark indices, SENSEX and NIFTY50, were trading flat during the afternoon session on Monday, May 18, amid buying in IT stocks.

In morning deals, the market had opened in the negative territory due to renewed tensions in West Asia, which led to a surge in crude oil prices. Furthermore, the Indian rupee hit an all-time low against the US dollar, which had also impacted the indices.

The SENSEX slumped as much as 1.4% to touch an intraday low of 74,180.26 during the opening bell. Meanwhile, the NIFTY50 reached the session’s low of 23,317.10.

At 1:05 PM, the S&P BSE SENSEX was edged higher by 99.44 points, or 0.13%, to 75,337.43, while NSE’s NIFTY50 was trading at 23,646.65, reflecting a 3.15 points, or 0.01% rise.

Buzzing stocks on May 18: Check list

NIFTY IT surged 2% on Monday, May 15, emerging as an outperformer despite the decline in broader market indices.

IT stocks rallied as investor sentiment improved following the decline in the Indian rupee against the US dollar. A weaker rupee is generally considered positive for IT companies because a large portion of their revenue comes from overseas markets, particularly the US. When the rupee depreciates, dollar-denominated earnings translate into higher revenue in rupee terms, supporting margins and profitability.

Furthermore, investor sentiment was further boosted by the continued strength in software and technology stocks on Wall Street. Gains in major US tech companies improved risk appetite globally and lifted optimism around the demand outlook for IT services firms.

Amber Enterprises' stock tumbled 18% to its intraday low of ₹6,980 apiece on the National Stock Exchange (NSE) on Monday, May 18, as investors turned cautious after the firm’s fourth-quarter results, followed by an earnings call.

The household appliances firm reported a consolidated net profit of ₹134 crore in the fourth quarter of the fiscal year (Q4 FY26), marking a growth of 16% from ₹116 crore in the same period last year.

The company's revenue from operations advanced 10% to ₹4,146 crore in the January to March period as compared to ₹3,754 crore in the year-ago period.

Amber Enterprises’ operating profit, also known as earnings before interest, taxes, depreciation, and amortisation (EBITDA), increased 21% to ₹357 crore as against ₹295 crore in the corresponding period last year. Its EBITDA margin also expanded to 8.6%, in contrast to 7.8% in the year-ago period. However, margins in Q4 FY26 were impacted due to a surge in commodity prices and currency depreciation.

Shares of ICICI Prudential Life Insurance Company Limited declined as much as 8.77% to hit their 52-week low level of ₹488.60 apiece on the NSE in the early trade on Monday, May 18.

The slide in stock is being witnessed after UK-based Prudential plc on Sunday announced that it would acquire a majority 75% stake in Bharti Life Insurance for ₹3,500 crore from Bharti Life Ventures Pvt Ltd and 360 ONE Asset Management.

Currently, Prudential is a partner with ICICI Bank with around a 22% stake in the life insurance venture. With the announcement of a majority stake in Bharti Life Insurance, Prudential has to pare back its stake in the existing venture to comply with regulatory requirements.

The transaction is for an initial cash consideration of ₹3,500 crore (about $389 million) payable on completion, Prudential Plc said in a statement.

The stock of Jupiter Life Line Hospitals advanced as much as 2.51% to hit the session’s peak of ₹1,359.80 per equity share on the NSE, after its board of directors approved a 1:5 stock split, along with announcing its earnings and approving an interim dividend for the 2025-26 financial year (FY26). Its board of directors considered and approved the sub-division or split of one existing equity share of the company, with a face value of ₹10 each, fully paid-up, into five equity shares, with a face value of ₹2 each, fully paid-up, according to a regulatory filing dated May 15.

Jupiter Life Line’s board of directors also considered and approved an interim dividend at the rate of 10% per equity share, with a face value of ₹10 each for FY26. Furthermore, it fixed Friday, May 22, 2026, as the record date for the same.

The company reported a 15.04% year-on-year (YoY) surge in its consolidated net profit to ₹50.62 crore in the fourth quarter of FY26 (Q4 FY26), compared to ₹44 crore in the same period last year.

Shares of leading generic injectable manufacturer Gland Pharma Ltd skyrocketed to hit a 52-week high on Monday, May 18, after the company released its latest set of data for the quarter ending March 2026.

The company reported a 96.56% increase in its consolidated profit after tax to ₹366.67 crore in the latest March quarter, compared to ₹186.54 crore in the year-ago period.

Its revenue from operations advanced 22.30% to ₹1,742.79 crore in Q4 FY26 as against ₹1,424.90 crore in the corresponding period of the previous fiscal year.

The company said that the revenue growth was backed by an increase in capacity and new product ramp-ups. Contract and pricing renegotiations, cost reduction steps, and operating leverage helped the margin profile, it added.

NCC stock slumped as much as 7% to touch an intraday low of ₹150.03 per equity share on Monday, after posting an 18.83% YoY fall in its consolidated net profit to ₹206.02 crore in Q4 FY26, compared to ₹253.82 crore in the year-ago period.

Its revenue from operations, however, rose 1.66% YoY to ₹6,232.71 crore in the March FY26 quarter, as against ₹6,130.88 crore.

Its board of directors also recommended a final dividend of ₹2.20 per equity share with a face value of ₹2 each, at 110%, for FY26, and fixed Friday, August 14, 2026, as the record date for the same.

Shares of Vodafone Idea (Vi) fell, despite reporting a consolidated net profit of ₹51,970 crore on Saturday—its first-ever in about six years—for the March quarter of FY2025-26, mainly due to relief in statutory liabilities, according to a company filing. The company had posted a loss of ₹7,167 crore in the same period a year ago.

Its operational metrics, however, show a loss of around ₹5,515 crore during the reported quarter and ₹24,059 crore for the fiscal year 2026 before exceptional items comprising relief on adjusted gross revenue (AGR).

Vi also plans to raise ₹4,730 crore from a Singapore-based entity of promoter Aditya Birla Group, a company filing said.